Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2012
09/20/2012US20120238606 Azilsartan organic amine salts, preparation method and use thereof
09/20/2012US20120238605 Otamixaban for treatment of elderly and renal impaired non-st elevation myocardial infarction patients
09/20/2012US20120238604 Cytotoxic compounds
09/20/2012US20120238603 Treatment for inflammatory bowel disease
09/20/2012US20120238602 Piperidine sulphonamide derivatives
09/20/2012US20120238601 Treatment of cancer
09/20/2012US20120238600 Tropinone benzylamines as beta-tryptase inhibitors
09/20/2012US20120238599 Heterocyclic compounds as mek inhibitors
09/20/2012US20120238598 Derivatives of 7 alkynyl-1,8 naphthyridones, preparation method thereof and use of same in therapeutics
09/20/2012US20120238597 Inhibiting EPH B-3 Kinase
09/20/2012US20120238596 Formulations comprising palonosetron
09/20/2012US20120238595 Therapeutic compounds
09/20/2012US20120238594 Azaspirodecanone compounds
09/20/2012US20120238593 Heterocyclic compounds and uses thereof
09/20/2012US20120238592 Use and Application of a Pharmaceutical Composition Containing a Mixture of Natural-Origin Heterocylcial Guanidine
09/20/2012US20120238591 Acyclovir formulations
09/20/2012US20120238590 Compositions for treating cancer-related fatigue and methods of screening thereof
09/20/2012US20120238589 Organic compounds
09/20/2012US20120238588 1H-Pyrrolo[2,3-B]Pyridines
09/20/2012US20120238587 Novel pyridopyrimidine derivatives and use thereof
09/20/2012US20120238586 Fatty acid acetylated salicylates and their uses
09/20/2012US20120238585 Fatty acid acetylated salicylates and their uses
09/20/2012US20120238584 5-HT1A receptor subtype agonist
09/20/2012US20120238583 Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitors
09/20/2012US20120238582 Quinazoline derivatives
09/20/2012US20120238581 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
09/20/2012US20120238580 MALEATE SALTS OF 6-(5-CHLORO-2-PYRIDYL)-5-[(4-METHYL-1-PIPERAZINYL)CARBONYLOXY]-7-OXO-6,7-DIHYDRO-5H-PYRROLO[3,4-b]PYRAZINE
09/20/2012US20120238579 New Compounds 806
09/20/2012US20120238578 Compositions useful as inhibitors of voltage-gated sodium channels
09/20/2012US20120238577 Prostaglandin transporter inhibitors and uses thereof
09/20/2012US20120238576 Triazine Derivatives and their Therapeutical Applications
09/20/2012US20120238575 Antiproliferative pyrimidyl, fused pyrimidyl and pyrimidyl hydrazones
09/20/2012US20120238574 (1, 1, 1,3,3,3 -hexafluoro-2 hydroxypropan- 2 -yl) phenyl derivative, pharmaceutical compositions thereof and their use for the treatment of atherosclerosis
09/20/2012US20120238573 Prodrugs of [4 [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(1h-pyrrolo-pyridin-yl)-methanones and synthesis thereof
09/20/2012US20120238572 Use of substituted quinazoline compounds in treating angiogenesis-related diseases
09/20/2012US20120238571 Indazole derivatives as pi 3-kinase
09/20/2012US20120238570 Inhibitors of the hedgehog pathway
09/20/2012US20120238569 Thiazole and thiophene compounds
09/20/2012US20120238568 Pyrido[2,3-b]pyrazin-8-substituted Compounds and Their Use
09/20/2012US20120238567 4,5,6,7-tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands
09/20/2012US20120238566 Use of cell autophagy (type ii cell apoptosis) inhibitors
09/20/2012US20120238565 Triazolopyridine compounds and their use as ask inhibitors
09/20/2012US20120238564 Imidazo pyrazines
09/20/2012US20120238563 Novel unsaturated tetracyclic tetrahydrofuran derivatives
09/20/2012US20120238562 Treatment of cancer by targeting molecules that influence mst1/stk4 signaling
09/20/2012US20120238561 Morpholinothiazoles as alpha 7 positive allosteric modulators
09/20/2012US20120238560 Oxazine Derivatives and their Use in the Treatment of Neurological Disorders
09/20/2012US20120238559 Novel compounds
09/20/2012US20120238558 Kinase inhibitors
09/20/2012US20120238557 Aminothiazine or aminooxazine derivative having amino linker
09/20/2012US20120238556 Crystalline methylthioninium chloride hydrates
09/20/2012US20120238555 Pharmaceutical composition containing irbesartan
09/20/2012US20120238554 Salts of potassium atp channel openers and uses thereof
09/20/2012US20120238553 Novel benzodioxolyl-oxadiazolyl-diazabicyclononane derivatives and their medical use
09/20/2012US20120238552 Pharmaceutical compositions comprising sorbitan esters
09/20/2012US20120238551 Substituted Phenoxypropylcycloamine Derivatives as Histamine-3 (H3) Receptor Ligands
09/20/2012US20120238550 Compound
09/20/2012US20120238549 Nuclear Hormone Receptor Modulators
09/20/2012US20120238548 1,4-oxazepines as bace1 and/or bace2 inhibitors
09/20/2012US20120238547 2, 3, 6 - triamino substituted pyridines as kv7 (kcnq) channel modulators
09/20/2012US20120238546 Gamma secretase modulators
09/20/2012US20120238545 Tricyclic pyrazol amine derivatives
09/20/2012US20120238544 Thieno- and furo-pyrimidine modulators of the histamine h4 receptor
09/20/2012US20120238543 Antiviral Compounds
09/20/2012US20120238542 Aminopyrazoloquinazolines
09/20/2012US20120238541 Pharmaceutical compounds
09/20/2012US20120238540 Amino-pyrimidine compounds as inhibitors of ikk epsilon and/or tbk1
09/20/2012US20120238539 Novel piperazine analogs as broad-spectrum influenza antivirals
09/20/2012US20120238538 Macrocyclic amides, pharmaceutical compositions, preparation methods and uses thereof
09/20/2012US20120238537 Synthetic bile acid compositions and methods
09/20/2012US20120238536 Method for Treating Retinal Conditions Using an Intraocular Tamponade
09/20/2012US20120238535 Topical formulation of low level clobetasol propionate for treating disorders of the skin and mucous membranes
09/20/2012US20120238534 Oral suspension of prednisolone acetate
09/20/2012US20120238533 (Heteroarylmethyl) Thiohydantoins as anticancer drugs
09/20/2012US20120238532 Treatment of human osteosarcoma
09/20/2012US20120238531 Isoxazolidine derivatives
09/20/2012US20120238530 Fatty acid acetylated salicylates and their uses
09/20/2012US20120238529 Triptolide prodrugs
09/20/2012US20120238528 Novel phosphonic acid compounds as inhibitors of serine proteases
09/20/2012US20120238526 Aconitine compounds, compositions, uses, and preparation thereof
09/20/2012US20120238525 Peritoneal dialysis solutions comprising glucose polymers
09/20/2012US20120238524 Water-soluble polysaccharide ethers and their use
09/20/2012US20120238523 Glycosaminoglycan mixtures
09/20/2012US20120238522 Carotenoid-containing compositions and methods
09/20/2012US20120238521 Compositions and Methods for the Treatment of Musculoskeletal Related Diseases and Disorders Using Metal Ion-Citrate Analog Complexes
09/20/2012US20120238520 Novel Medical Use
09/20/2012US20120238519 Ophthalmic composition containing alginic acid or salt thereof
09/20/2012US20120238518 Diazeniumdiolated compounds, pharmaceutical compositions, and method of treating cancer
09/20/2012US20120238516 Granulated anthelmintic preparations and delivery systems
09/20/2012US20120238515 Methods for preventing or treating sarcopenia and muscle atrophy in animals
09/20/2012US20120238514 Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use
09/20/2012US20120238513 Method for inhibiting activation of macrophages
09/20/2012US20120238512 Antithrombotic dual inhibitors comprising a biotin residue
09/20/2012US20120238511 2-deoxy-d-glucose formulations for prevention or treatment of neurodegenerative diseases
09/20/2012US20120238510 Crystalline form of benzylbenzene sglt2 inhibitor
09/20/2012US20120238509 Urocortin 2 analogs and uses thereof
09/20/2012US20120238501 Modulation Of Osteoclast Differentiation
09/20/2012US20120238500 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto
09/20/2012US20120238494 Methods for reducing gnrh-positive tumor cell proliferation
09/20/2012US20120238488 Compounds and methods for treating neoplasia
1 ... 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 ... 7860